Office of Research & Development |
![]() ![]() |
Project Number: | I01BX003851-01A2 |
Title: | Treatment of Deep Vein Thrombosis via Targeted Inhibition of the FXII-uPAR-pAkt2 Axis in Neutrophils |
Principal Investigator: | Evi Stavrou |
Location: | Cleveland, OH |
Congressional District Code: | 11 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | October 2019 - September 2023 |
FY 2021 Funding Amount: | $156,800 |
Total Award Amount (all years): |
$702,188 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: The overall goal of this proposal is to establish a targeted therapeutic strategy to disrupt the interaction of coagulation factor FXII (FXII) and urokinase plasminogen activator receptor (uPAR) to downregulate Akt2- mediated neutrophil activation for treatment of deep vein thrombosis (DVT). DVT is a leading cause of cardiovascular death. New anticoagulation therapies have been developed, however these therapeutic advances are all associated with increased rate of bleeding. Moreover, these curre... |